期刊
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
卷 308, 期 3, 页码 335-348出版社
ELSEVIER GMBH
DOI: 10.1016/j.ijmm.2017.12.002
关键词
Daptomycin; Antibiotic resistance; GraRS regulatory system; Serial passaging
资金
- German Research Foundation (DFG) [FOR854 SCHN1284/1-2, SFB/TRR 34]
- BONFOR program of the Medical Faculty, University of Bonn
- German Center for Infection Research (DZIF)
The first-in-class lipopeptide antibiotic daptomycin (DAP) is highly active against Gram-positive pathogens including beta-lactam and glycopeptide resistant strains. Its molecular mode of action remains enigmatic, since a defined target has not been identified so far and multiple effects, primarily on the cell envelope have been observed. Reduced DAP susceptibility has been described in S. aureus and enterococci after prolonged treatment courses. In line with its pleiotropic antibiotic activities, a unique, defined molecular mechanism of resistance has not emerged, instead non-susceptibility appears often accompanied by alterations in membrane composition and changes in cell wall homeostasis. We compared S. aureus strains HG001 and SG511, which differ primarily in the functionality of the histidine kinase GraS, to evaluate the impact of the GraRS regulatory system on the development of DAP non-susceptibility. After extensive serial passing, both DAP(R) variants reached a minimal inhibitory concentration of 31 mu g/ml and shared some phenotypic characteristics (e.g. thicker cell wall, reduced autolysis). However, based on comprehensive analysis of the underlying genetic, transcriptomic and proteomic changes, we found that both strains took different routes to achieve DAP resistance. Our study highlights the impressive genetic and physiological capacity of S. aureus to counteract pleiotropic activities of cell wall- and membrane-active compounds even when a major cell wall regulatory system is dysfunctional.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据